TSX: MFIwww.mapleleaffoods.comMISSISSAUGA, ON, July 3, 2025 /PRNewswire/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or the "Company") (TSX: MFI) will release its second quarter 2025 financial results on August 7, 2025 at 6:00 am ET. The release will be followed by a conference call and webcast beginning at 8:30 am ET. What: Maple Leaf Foods Q2 2025 Conference Call Who: Curtis Frank, President and Chief Executive Officer David Smales, Chief Financial Officer Dennis Organ, President, Pork Comp ...

NEW YORK, July 3, 2025 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE: OWL) ("Blue Owl") today announced it will release its financial results for the second quarter ended June 30, 2025 on Thursday, July 31, 2025 before market open. Blue Owl invites all interested persons to its webcast / conference call at 10 a.m. Eastern Time to discuss its results.Conference Call Information:The conference call will be broadcast live on the Shareholders section of Blue Owl's website at www.blueowl.com.Participants are also ...

DUBLIN, July 3, 2025 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced it will host a conference call and webcast for investors and analysts on Wednesday, July 30, 2025 at 8:30 a.m. Eastern Time to review its second quarter 2025 financial results.AerCap's second quarter 2025 earnings press release will be released before financial markets open in the United States on July 30, 2025. A copy of the press release will be posted on the "Investors" section of AerCap's we ...

Gold Finder Announces Next Phase of Target Development at West Madsen Gold Project, Red Lake, OntarioWest Madsen adjoins Madsen Mine property, owned by West Red Lake Gold Mines (WRLG), which recently announced the restart of the Madsen Gold MineJuly 03, 2025 8:00 AM EDT | Source: Gold Finder Resources Ltd.Vancouver, British Columbia--(Newsfile Corp. - July 3, 2025) - Gold Finder Resources Ltd. (TSXV: GLD) (OTCQB: GLDFF) ("Gold Finder" or the "Company") is pleased to announce summer fieldwork a ...

Group 1 - The article emphasizes the importance of innovation and disruption in the financial sector, particularly focusing on high-tech and early growth companies [1] - It highlights the potential investment opportunities in growth buyouts and value stocks, suggesting a strategic approach for investors [1] Group 2 - The article does not provide specific financial data or performance metrics related to any companies or sectors [2][3]

Core Viewpoint - Innoviz Technologies Ltd. has regained compliance with Nasdaq's minimum bid price requirement, confirming its closing bid price was at least $1.00 for 10 consecutive business days prior to the September 22, 2025 deadline [1][2][3] Company Summary - Innoviz is a leading Tier-1 supplier of high-performance, automotive-grade LiDAR sensors and perception software, aiming to enhance safety in autonomous vehicles [1][4] - The company operates globally, serving major automotive manufacturers and has been selected by premium car brands for consumer vehicles and various commercial applications [4]

High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treated Fresenius Medical Care is committed to expanding HighVolumeHDF therapy to all markets where it is not already present, including the United StatesBAD HOMBURG, Germany, July 3, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Sarepta Therapeutics, Inc. due to allegations of violations of federal securities laws related to misleading statements about the safety of its product ELEVIDYS [2][4]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in Sarepta between June 22, 2023, and June 24, 2025, to discuss their legal rights [1]. - There is a deadline of August 25, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Sarepta [2]. - The complaint alleges that Sarepta and its executives made false statements regarding the safety of ELEVIDYS, which posed significant risks to patients [4]. Group 2: Stock Price Impact - Following a safety update on March 18, 2025, where a patient died after treatment with ELEVIDYS, Sarepta's stock price fell by $27.81, or 27.44%, closing at $73.54 [5]. - On April 4, 2025, after the company disclosed that EU authorities requested a review of the death, the stock price dropped by $4.18, or 7.13%, closing at $54.43 [6]. - A second patient death was reported on June 15, 2025, leading to a significant stock price decline of $15.24, or 42.12%, closing at $20.91 [7][8]. - Following an FDA Safety Communication on June 24, 2025, regarding the investigation of acute liver failure risks, the stock price fell by $1.52, or 8.01%, closing at $17.46 [8][9]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3].

Apple iPhone sales in China rose in the second quarter of the year for the first time in two years, Counterpoint Research said, as the tech giant looks to turnaround its business in one of its most critical markets.Sales of iPhones in China jumped 8% year-on-year in the three months to the end of June, according to Counterpoint Research. It's the first time Apple has recorded growth in China since the second quarter of 2023.Apple's performance was boosted by promotions in May as Chinese e-commerce firms dis ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In 3D Systems To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in 3D System between August 13, 2024 and May 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, July 3, 2025 /PRNewswire/ -- Faruqi & Faruq ...